Skip to main content
. Author manuscript; available in PMC: 2021 Oct 9.
Published in final edited form as: Hepatology. 2020 Oct 9;72(4):1298–1309. doi: 10.1002/hep.31146

FIG. 2.

FIG. 2.

Kaplan Meier curves showing survival in ECC and its subtypes for statin users against statin nonusers. (A-C) Number at risk represents the number of patients at risk of death because of cancer at time points 2, 4, 6, 8, and 10 years from the diagnosis of cancer; (C) patients with dCCA with a history of statin use had significantly lower risk of cancer compared with statin nonusers.